Dravet Syndrome is a neurological condition with severe, drug resistant epilepsy
Dravet Syndrome begins in infancy with frequent and/or prolonged seizures. It has an estimated incidence of 1:20,000. Dravet Syndrome was previously known as Severe Myoclonic Epilepsy of Infancy (SMEI) and approximately 80% of those affected have a mutation in their SCN1A gene.
Dravet Syndrome is a lifelong condition and can affect all aspects of life. Every child or adult with Dravet Syndrome is different, with some more severely affected than others. As well as prolonged and/or frequent seizures, common issues include intellectual disability, movement and balance issues, speech and language delays, sleeping difficulties, sensory integration disorders, growth and nutrition issues, behavioural issues and dysautonomia.
Children with Dravet Syndrome often develop different types of seizures over time.
Current treatment options for Dravet Syndrome are limited, with focus on seizure control.

Diagnosing Dravet Syndrome
Dravet Syndrome is first and foremost a clinical diagnosis, based on the evolution of specific types of seizures.
Children with Dravet Syndrome typically have normal developmental progress in the first years of life. Often seizures first begin while associated with fever or febrile illness. These are typically prolonged, lasting 20 minutes or more, involving rhythmic shaking of one side of the body.
Children often develop different seizure types over time. Epilepsy in Dravet Syndrome is usually difficult to fully control with medication. Affected children may have repeated episodes of status epilepticus, prolonged seizures which are difficult to stop and require hospitalisation.

Specific Tests:
- Genetic testing: While Dravet syndrome is largely a clinical diagnosis, a high percentage of people with the syndrome test positive for abnormality in a specific gene, the SCN1A gene. So this gene defect is often a helpful means of confirming the diagnosis. Some other genes have also been implicated. Other investigations:
- A Brain MRI scan is usually normal in children presenting with this condition.
- An EEG (recording of electrical activity of the brain) will usually show abnormalities which confirm a tendency to epileptic seizures.
Other genetic epilepsies
There are other rare genetic epilepsies with similarities to Dravet Syndrome. Each rare genetic epilepsy has a mutation or change to a specific gene. Common features include drug resistant epilepsy and associated developmental delays. They can also have associated behavioural difficulties with a high incidence of ASD diagnosis, movement disorders and intellectual disability. This group of conditions are known as DEEs, or ‘Developmental epileptic encephalopathies’.
As genetic testing becomes more advanced, new genes associated with DEEs are being discovered all the time. Other implicated genes (although not as common as SCN1A) include SCN2A, KCNQ2, KCNQ3, KCNT1, PCDHI9, CHD2, DNM1, and STXBP1.


Lennox Gastaut Syndrome (LGS) is a childhood drug-resistant epilepsy which typically develops before the age of five. It is characterised by multiple seizure types, developmental delays/intellectual disability, and characteristic slow spike-wave patterns on an EEG. It often persists into adulthood. LGS can have many different causes. The disorder likely has a genetic component, although the specific genetic factors are not well understood. In some cases it is associated with physical changes in the brain such as a tumor, trauma or infection. In approximately 40% of cases the cause remains unknown.
At Dravet Syndrome Ireland, we have many families with a diagnosis of another rare genetic epilepsy that join our community. Although some medical treatments may differ, the supports we provide are equally relevant.
Receiving a diagnosis
Receiving a diagnosis of Dravet Syndrome or other severe genetic epilepsy for your child can be a very difficult and overwhelming time. If you would like to chat to another parent who has been through this process please contact us and we will arrange a call.
As parents of children with a diagnosis ourselves, we have found contact with other families invaluable at times.
We have a private Facebook support group for parents and caregivers.

Managing Epilepsy
Epilepsy is different for everyone. Seizures vary in length and type, and people with Dravet Syndrome and other genetic epilepsies often develop different types of seizures over time. It is recommended that any child or adult with epilepsy have regular reviews with their neurologist, at least once a year. Your clinician can help draw up a plan on how to best manage seizures. Each person’s plan will be different.

FAQs
Dravet Syndrome is a rare, lifelong neurological condition that usually begins in infancy. It causes frequent and often prolonged seizures and can also affect development, movement, behaviour, sleep and overall quality of life.
Dravet Syndrome affects approximately 1 in every 15,000–20,000 births. Although rare, it is one of the more recognised genetic epilepsy syndromes.
In around 80–90% of cases, Dravet Syndrome is caused by a change in the SCN1A gene. The vast majority of these genetic changes occur spontaneously and are not inherited.
Dravet Syndrome is a severe form of epilepsy, but it also involves broader neurological and developmental challenges beyond seizures alone.
